Most JAKi are likely to induce cytopenias, decreased neutrophil counts and anemia because of their more or less specific inhibition of JAK2 and erythropoietin together with other hematopoietic growth factors as IL-6 and IL-11 signaling [38,43,45,51,63,83,86,89]. Here, JAK2 is linked to anemia (phenotype).